nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenazopyridine—SCN5A—dilated cardiomyopathy	0.787	1	CbGaD
Phenazopyridine—SCN5A—purkinje fiber—dilated cardiomyopathy	0.042	0.407	CbGeAlD
Phenazopyridine—SCN5A—endocardium—dilated cardiomyopathy	0.0216	0.21	CbGeAlD
Phenazopyridine—SCN5A—sinoatrial node—dilated cardiomyopathy	0.0205	0.199	CbGeAlD
Phenazopyridine—SCN7A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.0068	0.0626	CbGpPWpGaD
Phenazopyridine—SCN11A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.00606	0.0558	CbGpPWpGaD
Phenazopyridine—SCN8A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.00555	0.0511	CbGpPWpGaD
Phenazopyridine—SCN9A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.00449	0.0413	CbGpPWpGaD
Phenazopyridine—SCN3A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.00429	0.0395	CbGpPWpGaD
Phenazopyridine—SCN2A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.00412	0.038	CbGpPWpGaD
Phenazopyridine—SCN4A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.00412	0.038	CbGpPWpGaD
Phenazopyridine—SCN1A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.00397	0.0366	CbGpPWpGaD
Phenazopyridine—SCN10A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.00397	0.0366	CbGpPWpGaD
Phenazopyridine—SCN7A—cardiac ventricle—dilated cardiomyopathy	0.00336	0.0325	CbGeAlD
Phenazopyridine—SCN7A—myocardium—dilated cardiomyopathy	0.00316	0.0306	CbGeAlD
Phenazopyridine—SCN7A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00261	0.024	CbGpPWpGaD
Phenazopyridine—SCN11A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00233	0.0214	CbGpPWpGaD
Phenazopyridine—SCN7A—heart—dilated cardiomyopathy	0.0022	0.0214	CbGeAlD
Phenazopyridine—SCN8A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00213	0.0196	CbGpPWpGaD
Phenazopyridine—SCN7A—cardiac atrium—dilated cardiomyopathy	0.00189	0.0183	CbGeAlD
Phenazopyridine—SCN5A—cardiac ventricle—dilated cardiomyopathy	0.00182	0.0176	CbGeAlD
Phenazopyridine—SCN5A—Cardiac Progenitor Differentiation—MYH6—dilated cardiomyopathy	0.00173	0.0159	CbGpPWpGaD
Phenazopyridine—SCN9A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00172	0.0159	CbGpPWpGaD
Phenazopyridine—SCN5A—myocardium—dilated cardiomyopathy	0.00171	0.0166	CbGeAlD
Phenazopyridine—SCN3A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00165	0.0152	CbGpPWpGaD
Phenazopyridine—SCN2A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00158	0.0146	CbGpPWpGaD
Phenazopyridine—SCN4A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00158	0.0146	CbGpPWpGaD
Phenazopyridine—SCN4A—heart—dilated cardiomyopathy	0.00154	0.0149	CbGeAlD
Phenazopyridine—SCN5A—Cardiac Progenitor Differentiation—TNNI3—dilated cardiomyopathy	0.00154	0.0142	CbGpPWpGaD
Phenazopyridine—SCN1A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00153	0.014	CbGpPWpGaD
Phenazopyridine—SCN10A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00153	0.014	CbGpPWpGaD
Phenazopyridine—SCN5A—Cardiac Progenitor Differentiation—TNNT2—dilated cardiomyopathy	0.00131	0.012	CbGpPWpGaD
Phenazopyridine—SCN5A—Cardiac Progenitor Differentiation—ACTC1—dilated cardiomyopathy	0.00131	0.012	CbGpPWpGaD
Phenazopyridine—SCN3A—heart—dilated cardiomyopathy	0.0012	0.0116	CbGeAlD
Phenazopyridine—SCN5A—heart—dilated cardiomyopathy	0.00119	0.0116	CbGeAlD
Phenazopyridine—SCN5A—cardiac atrium—dilated cardiomyopathy	0.00102	0.0099	CbGeAlD
Phenazopyridine—SCN7A—Axon guidance—SCN5A—dilated cardiomyopathy	0.000987	0.00909	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000929	0.00855	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—SCN5A—dilated cardiomyopathy	0.00088	0.0081	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000828	0.00762	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—SCN5A—dilated cardiomyopathy	0.000804	0.00741	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000757	0.00697	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000704	0.00648	CbGpPWpGaD
Phenazopyridine—SCN7A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000689	0.00634	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—SCN5A—dilated cardiomyopathy	0.000651	0.00599	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000628	0.00578	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—SCN5A—dilated cardiomyopathy	0.000622	0.00573	CbGpPWpGaD
Phenazopyridine—SCN11A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000614	0.00565	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000613	0.00564	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—SCN5A—dilated cardiomyopathy	0.000598	0.0055	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—SCN5A—dilated cardiomyopathy	0.000598	0.0055	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000586	0.00539	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—SCN5A—dilated cardiomyopathy	0.000577	0.00531	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—SCN5A—dilated cardiomyopathy	0.000577	0.00531	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000574	0.00529	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000563	0.00518	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000563	0.00518	CbGpPWpGaD
Phenazopyridine—SCN8A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000561	0.00517	CbGpPWpGaD
Phenazopyridine—SCN7A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000554	0.0051	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000543	0.005	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000543	0.005	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000518	0.00477	CbGpPWpGaD
Phenazopyridine—SCN11A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000493	0.00454	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000464	0.00427	CbGpPWpGaD
Phenazopyridine—SCN9A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000454	0.00418	CbGpPWpGaD
Phenazopyridine—SCN8A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000451	0.00415	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000444	0.00409	CbGpPWpGaD
Phenazopyridine—SCN3A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000434	0.004	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000427	0.00393	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000427	0.00393	CbGpPWpGaD
Phenazopyridine—SCN2A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000417	0.00384	CbGpPWpGaD
Phenazopyridine—SCN4A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000417	0.00384	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000416	0.00383	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000411	0.00379	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000411	0.00379	CbGpPWpGaD
Phenazopyridine—SCN10A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000402	0.0037	CbGpPWpGaD
Phenazopyridine—SCN1A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000402	0.0037	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000382	0.00351	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000371	0.00341	CbGpPWpGaD
Phenazopyridine—SCN9A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000365	0.00336	CbGpPWpGaD
Phenazopyridine—SCN3A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000349	0.00321	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000339	0.00312	CbGpPWpGaD
Phenazopyridine—SCN2A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000335	0.00309	CbGpPWpGaD
Phenazopyridine—SCN4A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000335	0.00309	CbGpPWpGaD
Phenazopyridine—SCN10A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000323	0.00298	CbGpPWpGaD
Phenazopyridine—SCN1A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000323	0.00298	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000297	0.00273	CbGpPWpGaD
Phenazopyridine—SCN5A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000283	0.0026	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000274	0.00253	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000265	0.00244	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000262	0.00242	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—ITGB1—dilated cardiomyopathy	0.00026	0.0024	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000252	0.00232	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000252	0.00232	CbGpPWpGaD
Phenazopyridine—SCN7A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000252	0.00232	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000243	0.00224	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000243	0.00224	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000242	0.00223	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000232	0.00214	CbGpPWpGaD
Phenazopyridine—SCN5A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000227	0.00209	CbGpPWpGaD
Phenazopyridine—SCN11A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000224	0.00207	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000212	0.00195	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—RAC1—dilated cardiomyopathy	0.000209	0.00193	CbGpPWpGaD
Phenazopyridine—SCN8A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000205	0.00189	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000202	0.00186	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000196	0.0018	CbGpPWpGaD
Phenazopyridine—Nephrolithiasis—Furosemide—dilated cardiomyopathy	0.000192	0.104	CcSEcCtD
Phenazopyridine—SCN3A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000187	0.00172	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—RAC1—dilated cardiomyopathy	0.000186	0.00172	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000186	0.00171	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.00018	0.00166	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.00018	0.00166	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000175	0.00162	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000173	0.0016	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000173	0.0016	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000172	0.00158	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000171	0.00157	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—RAC1—dilated cardiomyopathy	0.000171	0.00157	CbGpPWpGaD
Phenazopyridine—SCN9A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000166	0.00153	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000166	0.00152	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000164	0.00151	CbGpPWpGaD
Phenazopyridine—SCN3A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000159	0.00146	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—CD36—dilated cardiomyopathy	0.000158	0.00146	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000158	0.00145	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000158	0.00145	CbGpPWpGaD
Phenazopyridine—SCN4A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000152	0.0014	CbGpPWpGaD
Phenazopyridine—SCN2A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000152	0.0014	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000152	0.0014	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000152	0.0014	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000151	0.00139	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—RAC1—dilated cardiomyopathy	0.000149	0.00137	CbGpPWpGaD
Phenazopyridine—SCN10A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000147	0.00135	CbGpPWpGaD
Phenazopyridine—SCN1A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000147	0.00135	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—CD36—dilated cardiomyopathy	0.000141	0.0013	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—RAF1—dilated cardiomyopathy	0.000139	0.00128	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—RAC1—dilated cardiomyopathy	0.000138	0.00127	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—RAC1—dilated cardiomyopathy	0.000133	0.00122	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—RAC1—dilated cardiomyopathy	0.000132	0.00121	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—CD36—dilated cardiomyopathy	0.000129	0.00119	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—RAC1—dilated cardiomyopathy	0.000127	0.00117	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—RAC1—dilated cardiomyopathy	0.000127	0.00117	CbGpPWpGaD
Phenazopyridine—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.000124	0.0671	CcSEcCtD
Phenazopyridine—SCN11A—Axon guidance—RAF1—dilated cardiomyopathy	0.000124	0.00114	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000122	0.00113	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—RAC1—dilated cardiomyopathy	0.000122	0.00113	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—RAC1—dilated cardiomyopathy	0.000122	0.00113	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000122	0.00112	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—RAC1—dilated cardiomyopathy	0.000122	0.00112	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000117	0.00108	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—RAF1—dilated cardiomyopathy	0.000113	0.00104	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000113	0.00104	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000113	0.00104	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000108	0.000999	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000108	0.000999	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000107	0.000984	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—CD36—dilated cardiomyopathy	0.000104	0.000962	CbGpPWpGaD
Phenazopyridine—SCN5A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000103	0.000952	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—CD36—dilated cardiomyopathy	9.99e-05	0.00092	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—RAF1—dilated cardiomyopathy	9.9e-05	0.000911	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—RAC1—dilated cardiomyopathy	9.84e-05	0.000906	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—CD36—dilated cardiomyopathy	9.6e-05	0.000884	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—CD36—dilated cardiomyopathy	9.6e-05	0.000884	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—EGFR—dilated cardiomyopathy	9.51e-05	0.000876	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—RAC1—dilated cardiomyopathy	9.41e-05	0.000867	CbGpPWpGaD
Phenazopyridine—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	9.31e-05	0.0504	CcSEcCtD
Phenazopyridine—SCN10A—Developmental Biology—CD36—dilated cardiomyopathy	9.25e-05	0.000852	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—CD36—dilated cardiomyopathy	9.25e-05	0.000852	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—RAF1—dilated cardiomyopathy	9.14e-05	0.000842	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—RAC1—dilated cardiomyopathy	9.04e-05	0.000833	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—RAC1—dilated cardiomyopathy	9.04e-05	0.000833	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—RAF1—dilated cardiomyopathy	8.82e-05	0.000812	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—RAF1—dilated cardiomyopathy	8.75e-05	0.000805	CbGpPWpGaD
Phenazopyridine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	8.74e-05	0.0473	CcSEcCtD
Phenazopyridine—SCN10A—Developmental Biology—RAC1—dilated cardiomyopathy	8.72e-05	0.000803	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—RAC1—dilated cardiomyopathy	8.72e-05	0.000803	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—RAC1—dilated cardiomyopathy	8.59e-05	0.000791	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—EGFR—dilated cardiomyopathy	8.48e-05	0.000781	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—RAF1—dilated cardiomyopathy	8.4e-05	0.000774	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—RAF1—dilated cardiomyopathy	8.4e-05	0.000774	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—RAF1—dilated cardiomyopathy	8.1e-05	0.000746	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—RAF1—dilated cardiomyopathy	8.1e-05	0.000746	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—RAF1—dilated cardiomyopathy	8.07e-05	0.000743	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—EGFR—dilated cardiomyopathy	7.75e-05	0.000714	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—ITGB1—dilated cardiomyopathy	7.63e-05	0.000702	CbGpPWpGaD
Phenazopyridine—Visual impairment—Furosemide—dilated cardiomyopathy	7.47e-05	0.0404	CcSEcCtD
Phenazopyridine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	7.46e-05	0.0403	CcSEcCtD
Phenazopyridine—Pruritus—Spironolactone—dilated cardiomyopathy	7.16e-05	0.0387	CcSEcCtD
Phenazopyridine—Diarrhoea—Spironolactone—dilated cardiomyopathy	6.93e-05	0.0375	CcSEcCtD
Phenazopyridine—SCN7A—Developmental Biology—EGFR—dilated cardiomyopathy	6.79e-05	0.000625	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	6.68e-05	0.000615	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—RAF1—dilated cardiomyopathy	6.53e-05	0.000601	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—CD36—dilated cardiomyopathy	6.51e-05	0.000599	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—TNF—dilated cardiomyopathy	6.46e-05	0.000595	CbGpPWpGaD
Phenazopyridine—Vomiting—Spironolactone—dilated cardiomyopathy	6.44e-05	0.0348	CcSEcCtD
Phenazopyridine—Rash—Spironolactone—dilated cardiomyopathy	6.38e-05	0.0345	CcSEcCtD
Phenazopyridine—Dermatitis—Spironolactone—dilated cardiomyopathy	6.38e-05	0.0345	CcSEcCtD
Phenazopyridine—Headache—Spironolactone—dilated cardiomyopathy	6.34e-05	0.0343	CcSEcCtD
Phenazopyridine—Jaundice—Lisinopril—dilated cardiomyopathy	6.32e-05	0.0342	CcSEcCtD
Phenazopyridine—SCN9A—Axon guidance—EGFR—dilated cardiomyopathy	6.27e-05	0.000577	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—RAF1—dilated cardiomyopathy	6.24e-05	0.000575	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—RAC1—dilated cardiomyopathy	6.13e-05	0.000564	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—EGFR—dilated cardiomyopathy	6.05e-05	0.000557	CbGpPWpGaD
Phenazopyridine—Nausea—Spironolactone—dilated cardiomyopathy	6.01e-05	0.0325	CcSEcCtD
Phenazopyridine—SCN3A—Axon guidance—EGFR—dilated cardiomyopathy	6e-05	0.000552	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—RAF1—dilated cardiomyopathy	6e-05	0.000552	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—RAF1—dilated cardiomyopathy	6e-05	0.000552	CbGpPWpGaD
Phenazopyridine—Hepatitis—Lisinopril—dilated cardiomyopathy	5.82e-05	0.0315	CcSEcCtD
Phenazopyridine—SCN1A—Developmental Biology—RAF1—dilated cardiomyopathy	5.78e-05	0.000532	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—RAF1—dilated cardiomyopathy	5.78e-05	0.000532	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—EGFR—dilated cardiomyopathy	5.76e-05	0.000531	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—EGFR—dilated cardiomyopathy	5.76e-05	0.000531	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—TNF—dilated cardiomyopathy	5.76e-05	0.00053	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—RAF1—dilated cardiomyopathy	5.7e-05	0.000525	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—EGFR—dilated cardiomyopathy	5.56e-05	0.000512	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—EGFR—dilated cardiomyopathy	5.56e-05	0.000512	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—EGFR—dilated cardiomyopathy	5.53e-05	0.000509	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—TNF—dilated cardiomyopathy	5.27e-05	0.000485	CbGpPWpGaD
Phenazopyridine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	4.76e-05	0.0257	CcSEcCtD
Phenazopyridine—SCN9A—Developmental Biology—EGFR—dilated cardiomyopathy	4.48e-05	0.000412	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—EGFR—dilated cardiomyopathy	4.28e-05	0.000394	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—TNF—dilated cardiomyopathy	4.26e-05	0.000392	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—EGFR—dilated cardiomyopathy	4.11e-05	0.000379	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—EGFR—dilated cardiomyopathy	4.11e-05	0.000379	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—TNF—dilated cardiomyopathy	4.08e-05	0.000375	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—RAF1—dilated cardiomyopathy	4.07e-05	0.000374	CbGpPWpGaD
Phenazopyridine—Hypersensitivity—Furosemide—dilated cardiomyopathy	4.06e-05	0.0219	CcSEcCtD
Phenazopyridine—SCN10A—Developmental Biology—EGFR—dilated cardiomyopathy	3.97e-05	0.000365	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—EGFR—dilated cardiomyopathy	3.97e-05	0.000365	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—TNF—dilated cardiomyopathy	3.92e-05	0.000361	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—TNF—dilated cardiomyopathy	3.92e-05	0.000361	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—EGFR—dilated cardiomyopathy	3.91e-05	0.00036	CbGpPWpGaD
Phenazopyridine—Pruritus—Furosemide—dilated cardiomyopathy	3.9e-05	0.0211	CcSEcCtD
Phenazopyridine—SCN1A—Developmental Biology—TNF—dilated cardiomyopathy	3.78e-05	0.000348	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—TNF—dilated cardiomyopathy	3.78e-05	0.000348	CbGpPWpGaD
Phenazopyridine—Diarrhoea—Furosemide—dilated cardiomyopathy	3.77e-05	0.0204	CcSEcCtD
Phenazopyridine—Dyspepsia—Lisinopril—dilated cardiomyopathy	3.64e-05	0.0197	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	3.57e-05	0.0193	CcSEcCtD
Phenazopyridine—Vomiting—Furosemide—dilated cardiomyopathy	3.5e-05	0.0189	CcSEcCtD
Phenazopyridine—Rash—Furosemide—dilated cardiomyopathy	3.47e-05	0.0188	CcSEcCtD
Phenazopyridine—Dermatitis—Furosemide—dilated cardiomyopathy	3.47e-05	0.0188	CcSEcCtD
Phenazopyridine—Headache—Furosemide—dilated cardiomyopathy	3.45e-05	0.0187	CcSEcCtD
Phenazopyridine—Nausea—Furosemide—dilated cardiomyopathy	3.27e-05	0.0177	CcSEcCtD
Phenazopyridine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	3.05e-05	0.0165	CcSEcCtD
Phenazopyridine—Pruritus—Lisinopril—dilated cardiomyopathy	2.92e-05	0.0158	CcSEcCtD
Phenazopyridine—Diarrhoea—Lisinopril—dilated cardiomyopathy	2.83e-05	0.0153	CcSEcCtD
Phenazopyridine—SCN5A—Developmental Biology—EGFR—dilated cardiomyopathy	2.79e-05	0.000257	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—TNF—dilated cardiomyopathy	2.65e-05	0.000244	CbGpPWpGaD
Phenazopyridine—Vomiting—Lisinopril—dilated cardiomyopathy	2.63e-05	0.0142	CcSEcCtD
Phenazopyridine—Rash—Lisinopril—dilated cardiomyopathy	2.61e-05	0.0141	CcSEcCtD
Phenazopyridine—Dermatitis—Lisinopril—dilated cardiomyopathy	2.6e-05	0.0141	CcSEcCtD
Phenazopyridine—Headache—Lisinopril—dilated cardiomyopathy	2.59e-05	0.014	CcSEcCtD
Phenazopyridine—Nausea—Lisinopril—dilated cardiomyopathy	2.46e-05	0.0133	CcSEcCtD
